Inventor · disambiguated record
Mihael H. Polymeropoulos
Also filed as: POLYMEROPOULOS MIHAEL · POLYMEROPOULOS MIHAEL H · POLYMEROPOULOS MIHAEL HRLSTOS
62 granted patents·61 pending applications·360 citations·filing 1992–2025
99Inventor score
Files withVANDA PHARMACEUTICALS INC107US HEALTH4BIRZNIEKS GUNTHER2LAVEDAN CHRISTIAN2POLYMEROPOULOS MIHAEL H2
Top patents by PatentIndex Score
123 records- 0198US11324735B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2020·Granted May 10, 2022·7 cites·13 claims
- 0298US11285129B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Mar 29, 2022·8 cites·3 claims
- 0398US10980770B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2020·Granted Apr 20, 2021·7 cites·12 claims
- 0498US8785492B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Jul 22, 2014·41 cites·5 claims
- 0597US12201604B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2024·Granted Jan 21, 2025·1 cites·9 claims
- 0697US11667718B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·3 cites·10 claims
- 0797US10610510B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 7, 2020·9 cites·13 claims
- 0896US12447141B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2024·Granted Oct 21, 2025·1 cites·25 claims
- 0996US10653665B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Granted May 19, 2020·8 cites·20 claims
- 1096US10463655B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2016·Granted Nov 5, 2019·8 cites·7 claims
- 1196US10149829B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Dec 11, 2018·13 cites·14 claims
- 1295US11759446B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2021·Granted Sep 19, 2023·2 cites·14 claims
- 1395US11266622B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2020·Granted Mar 8, 2022·3 cites·7 claims
- 1494US11918556B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Mar 5, 2024·1 cites·3 claims
- 1594US11850229B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Dec 26, 2023·1 cites·3 claims
- 1694US11826339B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2022·Granted Nov 28, 2023·1 cites·4 claims
- 1794US11141400B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2020·Granted Oct 12, 2021·3 cites·10 claims
- 1894US11078289B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 3, 2021·5 cites·9 claims
- 1993US11918557B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2023·Granted Mar 5, 2024·1 cites·10 claims
- 2093US11737993B2Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Aug 29, 2023·3 cites·13 claims
- 2193US10449176B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2017·Granted Oct 22, 2019·5 cites·9 claims
- 2293US10179119B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2015·Granted Jan 15, 2019·10 cites·10 claims
- 2392US10987346B2Iloperidone for the treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·4 cites·13 claims
- 2492US10610511B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2019·Granted Apr 7, 2020·8 cites·19 claims
- 2592US9855241B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·5 cites·9 claims
- 2691US11833130B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Dec 5, 2023·1 cites·10 claims
- 2791US10772880B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2019·Granted Sep 15, 2020·6 cites·13 claims
- 2891US10376487B2Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2014·Granted Aug 13, 2019·11 cites·20 claims
- 2991US10265282B2Cancer treatmentVANDA PHARMACEUTICALS INC·Filed 2018·Granted Apr 23, 2019·6 cites·10 claims
- 3090US11723903B2Treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2021·Granted Aug 15, 2023·1 cites·11 claims
- 3190US11633377B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2021·Granted Apr 25, 2023·1 cites·11 claims
- 3290US11607408B2Method of treatment of schizophreniaVANDA PHARMACEUTICALS INC·Filed 2020·Granted Mar 21, 2023·2 cites·23 claims
- 3390US10945988B2Treatment of circadian rhythm disordersVANDA PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·3 cites·13 claims
- 3490US2024342120A1Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3589US12427132B2Method of improving sleepVANDA PHARMACEUTICALS INC·Filed 2022·Granted Sep 30, 2025·1 cites·10 claims
- 3689US10821099B2Use of tradipitant in motion sicknessVANDA PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·5 cites·20 claims
- 3788US12478619B2Method of treatment with milsaperidoneVANDA PHARMACEUTICALS INC·Filed 2024·Granted Nov 25, 2025·0 cites·14 claims
- 3887US12440470B2Liquid tasimelteon formulations and methods of use thereofVANDA PHARMACEUTICALS INC·Filed 2023·Granted Oct 14, 2025·0 cites·3 claims
- 3987US11845990B2Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotypeVANDA PHARMACEUTICALS INC·Filed 2021·Granted Dec 19, 2023·1 cites·7 claims
- 4087US11433057B2Method for improving or enhancing cognitionVANDA PHARMACEUTICALS INC·Filed 2017·Granted Sep 6, 2022·2 cites·12 claims
- 4187US2024325339A1Melatonin agonist treatmentVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4286US12146185B2Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidoneVANDA PHARMACEUTICALS INC·Filed 2021·Granted Nov 19, 2024·1 cites·13 claims
- 4386US2024293355A1Method of treatmentVANDA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4486US2023346719A1Multiple myeloma treatmentVANDA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4585US11214827B2Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidoneVANDA PHARMACEUTICALS INC·Filed 2019·Granted Jan 4, 2022·2 cites·4 claims
- 4684US10874659B2Iloperidone metabolite for use in the treatment of psychiatric disordersVANDA PHARMACEUTICALS INC·Filed 2013·Granted Dec 29, 2020·6 cites·7 claims
- 4782US10563259B2Method of treatment based on polymorphisms of the KCNQ1 geneVANDA PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·2 cites·11 claims
- 4882US5468610AThree highly informative microsatellite repeat polymorphic DNA markersUS HEALTH·Filed 1993·Granted Nov 21, 1995·73 cites·12 claims
- 4981US12318375B2Method of treatment with tradipitantVANDA PHARMACEUTICALS INC·Filed 2022·Granted Jun 3, 2025·0 cites·22 claims
- 5081US11458116B2Method of improving sleepVANDA PHARMACEUTICALS INC·Filed 2020·Granted Oct 4, 2022·1 cites·22 claims
Showing the top 50 of 123 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mihael H. Polymeropoulos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →